These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma. Suzuki M, Suzuki H, Yamamoto T, Mamada Y, Mizuno H, Tominaga T, Suga M, Suemori S, Kato Y, Sato A, Yamanouchi E, Sakuyama K, Maeyama S, Shinagawa T, Okabe K. Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925 [Abstract] [Full Text] [Related]
3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H. Hepatogastroenterology; 2001 Apr; 48(41):1409-15. PubMed ID: 11677976 [Abstract] [Full Text] [Related]
7. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma]. Tateishi H, Hasuike Y, Kinuta M, Furukawa J, Takata N, Maruyama H, Oi H, Yayoi E, Okamura J. Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903 [Abstract] [Full Text] [Related]
12. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. Yamamoto K, Masuzawa M, Kato M, Kurosawa K, Kaneko A, Ishida H, Imamura E, Park NJ, Shirai Y, Fujimoto K, Michida T, Hayashi N, Ikeda M. Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917 [Abstract] [Full Text] [Related]